Capsaicin topical Pregnancy and Breastfeeding Warnings
Capsaicin topical is also known as: Axsain, Capsicum Oleoresin, Capsin, Capzasin, Capzasin Back and Body, Capzasin Quick Relief, Capzasin-HP, Capzasin-HP Arthritis Formula, Capzasin-P, Castiva Warming, Dolorac, GNP Capsaicin, Icy Hot PM Patch, Pain Doctor, Qutenza, RT Capsin, Salonpas Gel-Patch, Salonpas Pain Patch with Capsaicin, Sloan's Liniment, Trixaicin, Trixaicin HP, Zostrix, Zostrix Diabetic Foot Pain, Zostrix Neuropathy, Zostrix-HP
Capsaicin topical Pregnancy Warnings
Capsaicin topical has been assigned to pregnancy category B by the FDA. There are no controlled data in human pregnancy. Animal studies have not revealed evidence of fetal teratogenicity at high human doses. Capsaicin topical should be used during pregnancy only when benefit outweighs risk.
Capsaicin topical Breastfeeding Warnings
There are no data on the excretion of capsaicin topical into human milk. Studies have demonstrated that capsaicin is excreted into the milk of lactating rats. The effects of capsaicin in the nursing infant are unknown. Capsaicin topical patches are administered as a single 60-minute application and capsaicin is rapidly cleared from the bloodstream. The manufacturer of the patches recommends that mothers can reduce infant exposure by not breast-feeding after treatment on the day of treatment.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.